Advertisement
The New England Journal of Medicine published a study last August in which patients with non-small-cell lung cancer, which is almost always a fatal lung cancer, were randomized into two groups. One got standard chemotherapy treatment, and the other group received standard chemotherapy treatment and an early palliative-care consultation that focused on pain and symptom management. The group that got standard chemotherapy plus palliative care, not surprisingly, experienced less pain and better quality of life than the group not receiving the palliative care. The surprising finding, though, was that they also lived about 30 percent longer.
Continue Learning about Palliative Care
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.